Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200030 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL217319 | 0.89 | — | — | |
| Bromide SCHEMBL28990248 | 0.80 | — | — | |
| Bromide SCHEMBL27657296 | 0.80 | — | — | |
| Bromide SCHEMBL28990250 | 0.80 | — | — | |
| Bromide SCHEMBL28990252 | 0.80 | — | — | |
| Bromide SCHEMBL31546681 | 0.76 | — | — | |
| Isopropylamine SCHEMBL668710 | 0.76 | — | — | |
| Isopropylamine SCHEMBL16446482 | 0.76 | — | — | |
| Bromide SCHEMBL9730734 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119861124-A | NAD (P) modification method, immobilization method and continuous analysis sensor | 三诺生物传感股份有限公司 | 2025-04-22 | — | — | CN | claimed |
| US-20250114447-A1 | VACCINE FOR EQUINE HERPESVIRUS | INTERVET INC. (US) | 2025-04-10 | — | — | US | claimed |
| CN-119144167-A | Perfluoro ether rubber sealing element | 安徽永正密封件有限公司 | 2024-12-17 | — | — | CN | claimed |
| EP-4428138-A1 | AKR1C3-ACTIVATED DNA ALKYLATING AGENT, AND MEDICAL APPLICATION THEREOF | Ascentawits Pharmaceuticals, Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| CN-118201940-A | AKR1C3 activated DNA alkylating agent and medical application thereof | 深圳艾欣达伟医药科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4380614-A1 | VACCINE FOR EQUINE HERPESVIRUS | Intervet International B.V. (NL) | 2024-06-12 | — | — | EP | claimed |
| CN-117509860-B | Flocculant and preparation method thereof | 西安碧清水处理技术研究院有限公司 | 2024-03-12 | — | — | CN | claimed |
| CN-117509860-A | Flocculant and preparation method thereof | 西安碧清水处理技术研究院有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-116178589-B | Amphiphilic lipoyl cationic chitosan derivative and preparation and application thereof | 中国科学院烟台海岸带研究所 | 2023-07-04 | — | — | CN | claimed |
| CN-116178589-A | Amphiphilic lipoyl cationic chitosan derivative and preparation and application thereof | 中国科学院烟台海岸带研究所 | 2023-05-30 | — | — | CN | claimed |
| US-20130303778-A1 | PHOSPHORAMIDATE ALKYLATOR PRODRUGS | THRESHOLD PHARMACEUTICALS, INC. | 2013-11-14 | — | — | US | claimed |
| US-7426441-B2 | Methods for determining renal toxins | OCIMUM BIOSOLUTIONS, INC. (US) | 2008-09-16 | — | — | US | claimed |
| US-7415358-B2 | Molecular toxicology modeling | OCIMUM BIOSOLUTIONS, INC. (US) | 2008-08-19 | — | — | US | claimed |
| EP-1392871-A4 | MOLECULAR TOXICOLOGY MODELING | GENE LOGIC INC (US) | 2006-04-19 | — | — | EP | claimed |
| US-20040072160-A1 | Molecular toxicology modeling | OCIMUM BIOSOLUTIONS, INC. | 2004-04-15 | — | — | US | claimed |
| EP-1392871-A2 | MOLECULAR TOXICOLOGY MODELING | Gene Logic, Inc. (US) | 2004-03-03 | — | — | EP | claimed |
| WO-2002095000-A2 | MOLECULAR TOXICOLOGY MODELING | GENE LOGIC, INC. (US) | 2002-11-28 | — | — | WO | claimed |
| EP-0550477-A4 | INACTIVATED MYCOPLASMA HYOPNEUMONIAE BACTERIN AND METHOD OF USE THEREOF | — | 1993-12-01 | — | — | EP | claimed |
| EP-0550477-A1 | INACTIVATED MYCOPLASMA HYOPNEUMONIAE BACTERIN AND METHOD OF USE THEREOF. | SOLVAY ANIMAL HEALTH INC (US) | 1993-07-14 | — | — | EP | claimed |
| WO-1992003157-A1 | INACTIVATED MYCOPLASMA HYOPNEUMONIAE BACTERIN AND METHOD OF USE THEREOF | SOLVAY ANIMAL HEALTH, INC. (US) | 1992-03-05 | — | — | WO | claimed |